Section 32

Section 32 accounts for 31 tracked companies with verified cap-table data, 31 of which disclose round sizes totalling $4.8B. The median disclosed raise is $100M, and the largest is EQRx at $750M, ahead of NewLimit ($682M) and Dialpad ($450M).

The names that recur most often on these portfolio cap tables are Section 32 (31 companies), Casdin Capital (7 companies), Andreessen Horowitz (5 companies), Alexandria Venture Investments (4 companies), GV (3 companies), ARCH Venture Partners (3 companies). By latest disclosed round, the market skews Series B (18), Series A (5), Series C (4), Series F (1).

• Companies tracked: 31
• Disclosed funding total: $4.8B across 31 companies
• Median disclosed raise: $100M
• Largest raise: EQRx — $750M
• Stage mix: Series B 18 · Series A 5 · Series C 4 · Series F 1
• Most recent dated round: 2026-06-01

Best funded Section 32 companies

1. EQRx — $750M (latest: Series B)
2. NewLimit — $682M (latest: Series C)
3. Dialpad — $450M (latest: Series F)
4. Thrive Earlier Detection — $367M (latest: Series B)
5. Metromile — $282M (latest: Series E)
6. ROME Therapeutics — $199M (latest: Series B)
7. Autobahn Therapeutics — $176M (latest: Series B)
8. Celsius Therapeutics — $148M (latest: Series B)
9. Cyclewell — $132M (latest: Series B)
10. BigHat Biosciences — $130M
11. Character Biosciences — $128M (latest: Series B)
12. Nested Therapeutics — $125M (latest: Series A)
13. Phaidra — $120M (latest: Series B)
14. Forward Networks — $112M (latest: Series D)
15. Satellite Bio — $110M (latest: Series A)

Section 32 — related firms and companies (56)

• EQRx
• NewLimit
• Dialpad
• Thrive Earlier Detection
• Metromile
• ROME Therapeutics
• Autobahn Therapeutics
• Celsius Therapeutics
• Investors like Google Ventures
• Current Health
• ONI
• Investors like Mayfield Fund
• Investors like Motivate Venture Capital
• Investors like Gaingels
• Wise Systems
• Phaidra
• Investors like Menlo Ventures
• Investors like Amplify Partners
• Section 32 co-investors 2026
• Exai Bio
• BigHat Biosciences
• Investors like Liquid 2 Ventures
• Investors like Capital One Ventures
• Koala Health
• Syllable
• Investors like Shasta Ventures
• Investors like Greycroft
• Investors like Ridge Ventures
• Teckro
• Satellite Bio
• Investors like QED Investors
• Investors like Polaris Partners
• Companies backed by Section 32
• Sola Security
• Nested Therapeutics
• Investors like Ventioneers
• Investors like Atlas Venture
• FARO
• Stairwell
• Cyclewell
• Investors like GIC
• Investors like Lux Capital
• MedCrypt
• Culture Biosciences
• Investors like AME Cloud Ventures
• Investors like Bienville Capital
• Investors like Sutter Hill Ventures
• Miroculus
• Forward Networks
• Investors like ARCH Venture Partners
• Investors like Khosla Ventures
• Investors like Section 32
• Legacy
• Character Biosciences
• Investors like ACME Capital
• Investors like Insight Partners

Section 32 profile · All research reports